# BRINZOLAMIDE
> **ANDA211914** · Abbreviated New Drug Application (Generic) · Sponsor: PADAGIS US · Approved 2023-07-28
## Drug
- **FDA Application Number:** ANDA211914
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** BRINZOLAMIDE
- **Generic name:** BRINZOLAMIDE
- **Active ingredients:** BRINZOLAMIDE
- **Dosage form:** SUSPENSION/DROPS
- **Route:** OPHTHALMIC
- **Marketing status:** Discontinued
- **Sponsor:** PADAGIS US
- **Manufacturer:** Padagis US LLC
- **First approval:** 2023-07-28
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211914)
---
*MORVS · CC0 1.0*